Bristol Myers Squibb (BMS) is set to enhance its computational capabilities by deploying an NVIDIA DGX SuperPOD, establishing one of the most advanced AI infrastructures in the life sciences sector.
This new infrastructure will significantly boost BMS's computational power and efficiency, allowing for up to ten times better performance per megawatt compared to previous systems. This advancement enables the company to tackle more complex AI tasks without a proportional increase in energy use, aligning with its commitment to sustainable practices in drug discovery and development.
The collaboration with NVIDIA builds on nearly three years of partnership, initially aimed at enhancing BMS's research and development efforts. This expansion is crucial as BMS continues to integrate AI into its scientific programs across various therapeutic areas, including oncology and immunology. The Chief Digital and Technology Officer at BMS, Greg Meyers, emphasized the importance of robust infrastructure in translating AI into tangible patient outcomes, noting the significant impact this investment has already had on their drug discovery processes.
AI is fundamentally transforming BMS's approach to medicine development. By automating tasks like target identification, researchers can focus on higher-value decisions, thereby increasing efficiency and accuracy. The company's “Predict First” methodology leverages AI to inform experimental designs, ensuring that scientific inquiries are data-driven from the outset. This strategic use of AI aims not just for speed but for higher success rates in advancing drug programs.
Ultimately, BMS envisions a model of hybrid intelligence, where AI and human expertise collaborate closely. The new computational infrastructure will support this vision, enabling researchers to utilize extensive proprietary data and specialized AI tools to innovate in drug discovery. As noted by NVIDIA's Rory Kelleher, this partnership positions BMS to redefine the boundaries of how medicines are developed, leveraging decades of scientific knowledge for groundbreaking advancements.